Lv11
100 积分 2025-12-19 加入
[Consensus on Application of Third-generation EGFR-TKI in EGFR Mutated NSCLC (2022 Version)]
2小时前
已完结
P3.12.35 Real-World Clinical Outcomes of Osimertinib in Patients With Recurrent EGFR Mutated Lung Adenocarcinoma: A Multicenter Study
19天前
已关闭
Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial
19天前
已完结
EP.12A.20 EGFR Inhibitors Combined with Intrathoracic Perfusion Manages Malignant Pleural Effusion in EGFR-Mutated Metastatic Lung Adenocarcinoma
5个月前
已关闭
Comparison of 10-year Survival Outcomes between CT Surveillance and Surgery for Ground-Glass Nodules
8个月前
已完结
Pulmonary Subsolid Nodules
8个月前
已完结
皖公网安备34019202002308
